Andere talen Dynavax Technologies Corporation

Aandelen

DVAX

US2681582019

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
11,17 ^USD	-2,19%		-1,50%	-20,10%

23/02	Dynavax Technologies rapporteert break-even winst over Q4, lagere omzet	MT
22/02	Transcript : Dynavax Technologies Corporation, Q4 2023 Earnings Call, Feb 22, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024	24/04
Dynavax Technologies Corporation Announces Chief Financial Officer Changes	01/04
Dynavax to Present at TD Cowen's 44th Annual Health Care Conference	28/02
Dynavax Technologies Reports Breakeven Q4 Earnings, Lower Revenue	23/02
Dynavax Technologies Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	22/02
Earnings Flash (DVAX) DYNAVAX TECHNOLOGIES Reports Q4 Revenue $55.6M, vs. Street Est of $52.7M	22/02
Dynavax Technologies Corporation Provides Revenue Guidance for the Year 2024	22/02
Dynavax Technologies Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/02
Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance	22/02
Dynavax to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 22, 2024	08/02
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights	08/01
Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference	04/01
Dynavax Technologies Corporation(NasdaqGS:DVAX) added to NASDAQ Biotechnology Index	18/12
Dynavax to Present at the 6th Annual Evercore ISI HealthCONx Conference	20/11
Dynavax Technologies Insider Sold Shares Worth $300,000, According to a Recent SEC Filing	07/11
Dynavax Technologies Insider Sold Shares Worth $282,400, According to a Recent SEC Filing	03/11
Dynavax Technologies: Q3 Earnings Snapshot	02/11
Earnings Flash (DVAX) DYNAVAX TECHNOLOGIES Reports Q3 Revenue $69.5M, vs. Street Est of $61.4M	02/11
Dynavax Technologies Corporation Revises Earnings Guidance for the Full Year 2023	02/11
Dynavax Reports Third Quarter 2023 Financial Results and Raises Full Year Revenue Guidance	02/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Dynavax Technologies Corporation

Aandelen

DVAX

US2681582019

Andere talen

Filters